By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Generic Adderall XR to Be Sold in 2016 Under Agreement Struck Between Shire and Sandoz
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Business > Finance > Generic Adderall XR to Be Sold in 2016 Under Agreement Struck Between Shire and Sandoz
BusinessFinance

Generic Adderall XR to Be Sold in 2016 Under Agreement Struck Between Shire and Sandoz

Susan Scutti
Susan Scutti
Share
0 Min Read
generic adderall
SHARE

generic adderallAdderall XR producer Shire has agreed to supply an authorized generic version of the attention-deficit/hyperactivity disorder (ADHD) drug to Sandoz Inc., the generic division of Novartis. 

generic adderallAdderall XR producer Shire has agreed to supply an authorized generic version of the attention-deficit/hyperactivity disorder (ADHD) drug to Sandoz Inc., the generic division of Novartis. The agreement calls for Shire to manufacture and supply Sandoz with all dosage strengths of the controlled-release form of the product, while Sandoz will distribute the product in the U.S. Adderall was originally approved by the U.S. Food and Drug Administration (FDA) in 1996 for the treatment of adults and pediatric patients six years of age and older with ADHD. The terms of the new agreement begin on July 1, 2016, at which point Sandoz will pay Shire a royalty on all sales of the authorized product. Shire earned $81.4 million from sales of the drug during the third quarter of this year, Reuters reported.

ADHD and Adderall

ADHD is a neurobiological condition that affects five percent of school age children, according to the American Psychiatric Association, though the Centers for Disease Control and Prevention believes that the numbers are higher. As of 2011, nearly 11 percent of children between the ages of four and 17 (6.4 million children) have been diagnosed with ADHD. The prevalence of children in that age group who take ADHD medication increased from just under five percent in 2007 to 6.1 percent in 2011. In as many as 60 percent of all cases, the symptoms of ADHD continue into adulthood; ADHD, then, affects four percent of all adults. According to IMS Health, in 2011, about 14 million monthly prescriptions (of ADHD drugs) were written for adults, which is two and a half times the 5.6 million prescriptions written in 2007.

Adderall is a mixture of four different amphetamine salts: dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate. The FDA lists heart-related problems, psychiatric problems, and circulation problems as possible side effects. Other potential effects include insomnia, nausea, decreased appetite, weight loss, headache, dizziness, and abdominal pain.

In 2005 Health Canada, the Canadian drug regulatory agency, suspended the sale of Adderall XR in the Canadian market. The Canadian action was based on U.S. post-marketing reports of sudden deaths in pediatric patients. At that time, the FDA issued a press release stating it had “been aware of these post-marketing cases, and evaluated the risk of sudden death with Adderall prior to approving the drug for treatment of ADHD in adults last year.” Canada almost immediately reversed its original ban, though it established new labeling guidelines to warn patients of possible side effects. 

Adderall is categorized as a “Schedule II” drug — along with Ritalin, Dexedrine, and cocaine — which under the system of classification used by the Drug Enforcement Agency indicates a substance with a high potential for abuse. According to the National Institute on Drug Abuse, Adderall falls within the classes of prescription drugs that are commonly abused.

(image: FtWashGuy, CC-BY-SA-3.0-migrated)

TAGGED:AdderallADHDpharmaSandozShire
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

dental care
Importance of Good Dental Care for Health and Confidence
Dental health Specialties
October 2, 2025
AI in Healthcare
AI in Healthcare: Technology is Transforming the Global Landscape
Global Healthcare Policy & Law Technology
October 1, 2025
Choosing the Right Swimwear for Health and Safety
News
September 30, 2025
sports concussions
Concussion In Sports: How Common They Are And What You Need To Know
Infographics
September 28, 2025

You Might also Like

Reducing Pre-Term Births; Where Public Health Campaigns Can Make a Difference

January 27, 2012

Global Size and Growth of Spine Surgery Market Segments

July 7, 2011

Getting Value from Technology in Healthcare Is All about People

November 6, 2014
willing provider
BusinessPolicy & Law

The Willing Provider Problem

July 17, 2013
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?